Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €1.50 EUR
Change Today -0.041 / -2.66%
Volume 0.0
AQL On Other Exchanges
Symbol
Exchange
NASDAQ GM
As of 2:29 PM 08/31/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for arqule inc (AQL)

Year over year, ArQule Inc. has seen revenues shrink from $15.9M USD to $11.3M USD, though the company was able to grow net income from a loss of $24.6M USD to a smaller loss of $23.4M USD.
Currency in
Millions of US Dollars
As of:Dec 31
2011
Reclassified
Dec 31
2012
Reclassified
Dec 31
2013
Reclassified
Dec 31
2014
4 Year
Trend
Revenues47.336.415.911.3
TOTAL REVENUES47.336.415.911.3
Cost of Goods Sold45.034.027.622.3
GROSS PROFIT2.32.4-11.6-11.0
Selling General & Admin Expenses, Total13.413.912.812.2
Other Operating Expenses----0.71.1
OTHER OPERATING EXPENSES, TOTAL13.413.913.513.3
OPERATING INCOME-11.1-11.4-25.1-24.3
Interest Expense0.00.00.00.0
Interest and Investment Income0.30.40.50.3
NET INTEREST EXPENSE0.30.40.50.2
EBT, EXCLUDING UNUSUAL ITEMS-10.8-11.0-24.7-24.0
Gain (Loss) on Sale of Investments0.00.10.10.3
Gain (Loss) on Sale of Assets------0.4
EBT, INCLUDING UNUSUAL ITEMS-10.8-10.9-24.6-23.4
Earnings from Continuing Operations-10.8-10.9-24.6-23.4
NET INCOME-10.8-10.9-24.6-23.4
NET INCOME TO COMMON INCLUDING EXTRA ITEMS-10.8-10.9-24.6-23.4
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS-10.8-10.9-24.6-23.4
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AQL:GR €1.50 EUR -0.041

AQL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AVEO Pharmaceuticals Inc $1.37 USD -0.05
CrystalGenomics Inc 13,050 KRW -350.00
Curis Inc $2.62 USD +0.0259
Cytokinetics Inc $6.91 USD -0.09
Rigel Pharmaceuticals Inc $3.00 USD +0.01
View Industry Companies
 

Industry Analysis

AQL

Industry Average

Valuation AQL Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 9.6x
Price/Book 3.3x
Price/Cash Flow NM Not Meaningful
TEV/Sales 5.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ARQULE INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.